Back to Search
TIM GRETEN, M.D.
M.D.
Hematology & Oncology Physician
NPI: 1518231000Individual
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
D0048405(MD)
Research & Publications (20)
Cetuximab plus cisplatin-5-fluorouracil versus cisplatin-5-fluorouracil alone in first-line metastatic squamous cell carcinoma of the esophagus: a randomized phase II study of the Arbeitsgemeinschaft Internistische Onkologie.
PMID 19549707·Ann Oncol·2009
3-trial
[Sorafenib for the treatment of HCC--the beginning of a new era in the treatment of HCC].
PMID 19156592·Z Gastroenterol·2009
6-review
Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor.
PMID 19551844·Hepatology·2009
8-other
Molecular therapy for the treatment of hepatocellular carcinoma.
PMID 19018262·Br J Cancer·2009
6-review
Tumour-associated transcripts and EGFR deletion variants in colorectal cancer in primary tumour, metastases and circulating tumour cells.
PMID 18936523·Cell Oncol·2008
8-other
Circulating tumour cells as a predictive factor for response to systemic chemotherapy in patients with advanced colorectal cancer.
PMID 19383356·Mol Oncol·2008
8-other
Myeloid-derived suppressor cells in inflammatory bowel disease: a new immunoregulatory pathway.
PMID 18674538·Gastroenterology·2008
7-preclinical
Complement 5a receptor inhibition improves renal allograft survival.
PMID 18753257·J Am Soc Nephrol·2008
7-preclinical
[Suspicion of a newly appearing hypertrophic obstructive cardiomyopathy in a patient treated for hepatocellular carcinoma].
PMID 18924054·Dtsch Med Wochenschr·2008
5-case
A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells.
PMID 18485901·Gastroenterology·2008
8-other
Impaired TRAIL-dependent cytotoxicity of CD1c-positive dendritic cells in chronic hepatitis C virus infection.
PMID 18233993·J Viral Hepat·2008
8-other
[Hepatocellular carcinoma - diagnosis and treatment].
PMID 18785082·Dtsch Med Wochenschr·2008
6-review
Peptide-beta2-microglobulin-major histocompatibility complex expressing cells are potent antigen-presenting cells that can generate specific T cells.
PMID 17472719·Immunology·2007
8-other
Transarterial chemoembolization using degradable starch microspheres and iodized oil in the treatment of advanced hepatocellular carcinoma: evaluation of tumor response, toxicity, and survival.
PMID 17548248·Hepatobiliary Pancreat Dis Int·2007
8-other
Participation in screening colonoscopy in first-degree relatives from patients with colorectal cancer.
PMID 17761708·Ann Oncol·2007
8-other
Necrotic tumor cell death in vivo impairs tumor-specific immune responses.
PMID 17237406·J Immunol·2007
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- NCI BUILDING 10 RM 12N226, 10 CENTER DRIVE
BETHESDA, MD 20892 - Phone
- (301) 451-4723
Quick Facts
- NPI
- 1518231000
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile